|
Volumn 11, Issue 3, 2003, Pages 259-262
|
Expression of survivin, Fas, bcl-2 and bax in bone marrow cells from acute myeloid leukemia patients and its clinical significance
a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BAX PROTEIN, HUMAN;
BIRC5 PROTEIN, HUMAN;
FAS ANTIGEN;
MESSENGER RNA;
MICROTUBULE ASSOCIATED PROTEIN;
ONCOPROTEIN;
PROTEIN BAX;
PROTEIN BCL 2;
TUMOR MARKER;
TUMOR PROTEIN;
ACUTE GRANULOCYTIC LEUKEMIA;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BIOSYNTHESIS;
BONE MARROW CELL;
DRUG EFFECT;
FEMALE;
FLOW CYTOMETRY;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
ADOLESCENT;
ADULT;
AGED;
ANTIGENS, CD95;
ANTINEOPLASTIC AGENTS;
BCL-2-ASSOCIATED X PROTEIN;
BONE MARROW CELLS;
FEMALE;
FLOW CYTOMETRY;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
LEUKEMIA, MYELOCYTIC, ACUTE;
MALE;
MICROTUBULE-ASSOCIATED PROTEINS;
MIDDLE AGED;
NEOPLASM PROTEINS;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
RNA, MESSENGER;
TUMOR MARKERS, BIOLOGICAL;
|
EID: 0042352133
PISSN: 10092137
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (0)
|